文献速递分子诊断质量管理与危急值

超越分析能力:中国HPV检测实验室在国家级室间质评网络中的信息连续性缺口

Beyond analytical proficiency: information continuity gaps in human papillomavirus testing laboratories within China's national external quality assessment network.
PubMed 文献 · Clin Chem Lab Med · 2026-10-28

该研究在2026年国家临检中心HPV16/18室间质评网络中嵌入机构级网络调查,收集2025年运营数据并与室间质评结果链接。在111家有效应答实验室中,99%的室间质评结果完全正确,但仅59%能检索到任何下游信息,37%能完全去重同一女性的重复检测。临床服务整合与下游信息可及性相关(OR 4.01,95%CI 1.71-9.84;p=0.001)。

要点

  • HPV检测实验室分析合格率高,但下游结果检索和患者去重能力不足。
  • 仅59%实验室能检索任何下游细胞学、阴道镜或组织病理信息。
  • 临床服务整合与下游信息可及性独立相关。

核心结论

  • 高分析能力并不代表检验全流程闭环,患者身份解析和下游结果可检索性值得作为候选质量指标进一步标准化和验证。

研究设计与样本

  • 在2026年国家临检中心HPV16/18室间质评网络中嵌入自愿性机构级网络调查,收集2025年运营数据,并与2025年室间质评结果链接。
  • 共957家受邀框架实验室,获得111份有效应答,109份匹配框架,应答率11%;89家有2025年室间质评记录。

主要发现

  • 89家有2025年室间质评记录的应答者中,88家(99%)HPV16/18结果完全正确。
  • 111家实验室中,65家(59%)能检索任何下游信息,14家(13%)报告接近完全可及,41家(37%)能完全去重同一女性的重复检测。
  • 临床服务整合与下游信息可及性相关(OR 4.01,95%CI 1.71-9.84;p=0.001)。
  • 将暴露限制为筛查/临床报告功能时,关联仍存在(OR 3.30,95%CI 1.40-8.20;p=0.006)。

临床怎么用

  • HPV检测实验室除关注分析准确性外,应重视患者唯一标识去重和下游结果追溯能力。
  • 可将患者去重和下游结果可检索性作为分子诊断全流程质量改进的候选指标。

局限性

  • 应答率仅11%,可能存在选择偏倚。
  • 为自愿性调查,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: External quality assessment (EQA) emphasizes analytical proficiency, but actionable molecular testing also depends on extra-analytical processes that link results to unique patients and subsequent care. We assessed patient de-duplication and downstream-result retrievability in HPV testing laboratories, using EQA performance as an analytical-quality anchor, and explored these capabilities as candidate quality indicators for the total testing process. METHODS: A voluntary institution-level web survey was embedded in the 2026 National Center for Clinical Laboratories HPV16/18 EQA network and collected 2025 operational data. Survey records were linked to 2025 EQA results. The primary outcome was any laboratory access to downstream cytology, colposcopy, or histopathology information after an HPV-positive result. Associations were examined using prespecified Firth logistic regression, with ordinal and narrower-exposure sensitivity analyses. RESULTS: Among 957 unique invitation-frame laboratories, 111 valid responses were obtained; 109 matched the frame (response rate 11 %). Among 89 respondents with 2025 EQA records, 88 (99 %) had fully correct HPV16/18 results. In contrast, 65/111 (59 %) laboratories could retrieve any downstream information, 14/111 (13 %) reported near-complete access, and 41/111 (37 %) could fully de-duplicate repeated tests from the same woman. Clinical service integration was associated with downstream information availability (OR 4.01, 95 % CI 1.71-9.84; p=0.001); the association persisted when exposure was restricted to screening/clinical-reporting functions (OR 3.30, 95 % CI 1.40-8.20; p=0.006). CONCLUSIONS: High analytical proficiency did not imply closure of the extra-analytical testing loop. Patient identity resolution and downstream-result retrievability merit further standardization and validation as candidate quality indicators for molecular diagnostics and EQA-linked quality improvement.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Lin, Zhang. Beyond analytical proficiency: information continuity gaps in human papillomavirus testing laboratories within China's national external quality assessment network. Clin Chem Lab Med. 2026. PMID: 42935277. doi:10.1515/cclm-2026-1582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。